中文 | English
Return
Total: 36 , 1/4
Show Home Prev Next End page: GO
Author:(Qiongqiong YANG)

1.Neurospecific transmembrane protein 240 colocalizes with peroxisomes and activates Rho GDP dissociation inhibitor β.

Qiongqiong HU ; Wenpei LI ; Lixia XU ; Ruilei GUAN ; Dongya ZHANG ; Jiaojiao JIANG ; Ning WANG ; Gaiqing YANG

Journal of Southern Medical University 2025;45(6):1260-1269

2.Mechanism of Liangxue Tuizi Formula in the treatment of Henoch-Sch?nlein purpura rats via reactive oxygen species-mediated activation of NLRP3 inflammasome

Jinwan SONG ; Xianqing REN ; Qiongqiong XING ; Yifan LI ; Manxiang YANG

Chinese Journal of Comparative Medicine 2025;35(4):21-30

3.Changes and Trends in the microbiological-related standards in the Chinese Pharmacopoeia 2025 Edition

FAN Yiling ; ZHU Ran ; YANG Yan ; JIANG Bo ; SONG Minghui ; WANG Jing ; LI Qiongqiong ; LI Gaomin ; WANG Shujuan ; SHAO Hong ; MA Shihong ; CAO Xiaoyun ; HU Changqin ; MA Shuangcheng, ; YANG Meicheng

Drug Standards of China 2025;26(1):093-098

4.Establishment and evaluation of preservation efficacy for preservative⁃free cosmetics sold online

Yan YANG ; Qiongqiong LI ; Yiling FAN

Shanghai Journal of Preventive Medicine 2025;37(8):700-704

5.Changes and Trends in the microbiological-related standards in the Chinese Pharmacopoeia 2025 Edition

Yiling FAN ; Ran ZHU ; Yan YANG ; Bo JIANG ; Minghui SONG ; Jing WANG ; Qiongqiong LI ; Gaomin LI ; Shujuan WANG ; Hong SHAO ; Shihong MA ; Xiaoyun CAO ; Changqin HU ; Shuangcheng MA ; Meicheng YANG ; Jun ZHANG

Drug Standards of China 2025;26(1):93-98

6.Mechanism of Liangxue Tuizi Formula in the treatment of Henoch-Sch?nlein purpura rats via reactive oxygen species-mediated activation of NLRP3 inflammasome

Jinwan SONG ; Xianqing REN ; Qiongqiong XING ; Yifan LI ; Manxiang YANG

Chinese Journal of Comparative Medicine 2025;35(4):21-30

7.Interpretation of"Guideline 9212 risk assessment and control of objectionable microorganisms for non-sterile products"in Chinese Pharmacopoeia 2025 Edition

Minghui SONG ; Ning ZHANG ; Qiongqiong LI ; Hong SHAO ; Yiling FAN ; Meicheng YANG ; Shihong MA ; Jun ZHANG ; Changqin HU

Drug Standards of China 2025;26(5):455-461

8.Interpretation of"Guideline 9212 risk assessment and control of objectionable microorganisms for non-sterile products"in Chinese Pharmacopoeia 2025 Edition

Minghui SONG ; Ning ZHANG ; Qiongqiong LI ; Hong SHAO ; Yiling FAN ; Meicheng YANG ; Shihong MA ; Jun ZHANG ; Changqin HU

Drug Standards of China 2025;26(5):455-461

9.Based on Metabolomics,the Mechanism of Qufengxiaoschonlein Decoction in the Treatment of Henoch-Schonlein Purpura was lnvestigated

Hua LIU ; Xianqing REN ; Weixia LI ; Qiongqiong XING ; Leying XI ; Yifan LI ; Manxiang YANG ; Ying DING

World Science and Technology-Modernization of Traditional Chinese Medicine 2025;27(3):612-625

10.Based on Metabolomics,the Mechanism of Qufengxiaoschonlein Decoction in the Treatment of Henoch-Schonlein Purpura was lnvestigated

Hua LIU ; Xianqing REN ; Weixia LI ; Qiongqiong XING ; Leying XI ; Yifan LI ; Manxiang YANG ; Ying DING

World Science and Technology-Modernization of Traditional Chinese Medicine 2025;27(3):612-625

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 36 , 1/4 Show Home Prev Next End page: GO